63500-84-5

Basic information

• Product Name: 4-Thiazolidinone, 3-methyl-2-[(4-nitrophenyl)imino]-
• CAS NO: 63500-84-5
• Molecular Formula: C10H9N3O3S
• Molecular Weight: 251.266
• Mol File: 63500-84-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-Thiazolidinone, 3-methyl-2-[(4-nitrophenyl)imino]-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Thiazolidinone, 3-methyl-2-[(4-nitrophenyl)imino]-(63500-84-5)
• EPA Substance Registry System: 4-Thiazolidinone, 3-methyl-2-[(4-nitrophenyl)imino]-(63500-84-5)

Safety Data

• Hazardous Substances Data: 63500-84-5(Hazardous Substances Data)

Upstream product

• 100-01-6 4-nitro-aniline 
• 16361-69-6 1-(4-nitrophenyl)-3-methyl-thiourea 
• 105-36-2 ethyl bromoacetate 
• 74386-43-9 C₉H₆N₃O₃S^(1-)*Na⁽¹⁺⁾ 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 
• 27052-11-5 2-(4-nitrophenylimino)thiazolidin-4-one 

Downstream Products

• 1186634-18-3 5-(4-(4-cyclohexylbenzyloxy)benzylidene)-3-methyl-2-(4-nitrophenyimino)thiazolidin-4-one 
• 1186634-21-8 2-(4-aminophenylimino)-3-methylthiazolidin-4-one 
• 1186634-22-9 (4-(3-methyl-4-oxothiazolidin-2-ylideneamino)phenylamino)acetic acid ethyl ester 
• 1186634-25-2 5-(4-(3-methyl-4-oxo-1,3-thiazolidin-2-ylideneamino)phenyl)-1,1-dioxo-1λ6-[1,2,5]thiadiazolidin-3-one 
• 1186634-24-1 ((4-((3-methyl-4-oxo-1,3-thiazolidin-2-ylidene)amino)phenyl)(sulfamoyl)amino)acetic acid ethyl ester 
• 1186634-19-4 2-(4-aminophenylimino)-5-(4-(4-cyclohexylbenzyloxy)benzylidene)-3-methylthiazolidin-4-one 
• 1186633-83-9 N-(4-(5-(4-(4-cyclohexylbenzyloxy)benzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)phenyl)oxalamic acid 
• 1186634-20-7 N-(4-(5-(4-(4-cyclohexylbenzyloxy)benzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)phenyl)oxalamic acid ethyl ester 
• 1186633-78-2 5-(4-(5-(4-(4-cyclohexylbenzyloxy)benzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)phenyl)-1,1-dioxo-1λ6-[1,2,5]thiadiazolidin-3-one 

Relevant articles and documents

NOVEL PROTEIN TYROSINE PHOSPHATASE - IB INHIBITORS

The present invention relates to the novel compounds of the general formula (I), wherein the symbols are same as described in specification, their pharmaceutically acceptable salts, their tautomeric forms, their stereoisomers, pharmaceutical compositions containing them, to process and intermediates for the preparation of the above said compounds, having the utility of these compounds in medicine and to methods for their therapeutic use, and their use in the treatment of diabetes and related diseases.

REACTIVITY AND TAUTOMERISM OF AZOLIDINES. XXXVI. EFFECT OF THE NATURE OF ALKYLATING AGENT AND SOLVENT ON THE DUAL REACTIVITY ON THE AMBIDENT ANIONS OF 2-ARYLIMINOTHIAZOLIDIN-4-ONES

Increase in the "hardness" of the alkylating agent leads to an increase in the degree of reaction at the cyclic nitrogen atom of the thiazolidine ring.The effect of the solvent on the direction of methylation is due to the solvating ability both with respect to the cation and with respect to the ambident anion.